We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 1 of 1
Most popular |Most recent


The Last Two Years: A Summary of 2014-2015 Office of Prescription Drug Promotion (OPDP) Enforcement and Relevant FDA Guidance

USA - March 1 2016 The past two years have created a bit of uncertainty for life sciences promotional review professionals. With fewer enforcement letters, high-profile...

Kim C. Capone.